Tafas v. Kappos
This text of 586 F.3d 1369 (Tafas v. Kappos) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
NOTE: This order is nonprecedential.
United States Court of Appeals for the Federal Circuit 2008-1352
TRIANTAFYLLOS TAFAS,
Plaintiff-Appellee,
and
SMITHKLINE BEECHAM CORPORATION (doing business as GlaxoSmithKline), SMITHKLINE BEECHAM PLC, and GLAXO GROUP LIMITED (doing business as GlaxoSmithKline),
Plaintiffs-Appellees,
v.
DAVID J. KAPPOS, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, and UNITED STATES PATENT AND TRADEMARK OFFICE,
Defendants-Appellants.
Appeal from the United States District Court for the Eastern District of Virginia in consolidated case nos. 1:07-CV-846 and 1:07-CV-1008, Senior Judge James C. Cacheris.
ORDER
Upon consideration of the court's July 28, 2009 order granting the parties' joint
motion for a stay of en banc proceedings,
IT IS ORDERED THAT:
Absent further order of this court, the appellants' additional en banc brief is due
within 60 days of the date of filing of this order. Absent further order of this court, the
parties shall file the required copies of their original briefs within 60 days of the date of filing of this order. The remaining brief due dates should be calculated in compliance
with this court's July 6, 2009 order.
FOR THE COURT
August 21, 2009 /s/ Jan Horbaly Date Jan Horbaly Clerk
cc: Steven J. Moore, Esq. John M. Desmarais, Esq. James A. Toupin, Esq.
2008-1352 -2-
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
586 F.3d 1369, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tafas-v-kappos-cafc-2009.